Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...

Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company lead ...

Global Parkinson’s disease cases are projected to more than double to 25.2 million by 2050, driven largely by aging ...

Researchers at the WEHI Parkinson’s Disease Research Centre have made a huge leap forward in the fight against Parkinson’s disease, solving a decades-long mystery. In a major breakthrough, they have ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

The prevalence of Parkinson disease is projected to increase through 2050, according to a study published online Marc ...

A recent study predicts that by 2050, 25.2 million people worldwide will be living with Parkinson’s disease—more than double ...

Philip Lewis Pittman Philip Pittman was born on 3/24/1937 in Centerville, Iowa. He passed away in Albuquerque, New Mexico on 2/23/2025 due to advanced symptoms of Parkinson's Disease. Phil spent most ...

Parkinson's disease cases are projected to double globally by 2050, reaching 25 million individuals, according to a recent ...

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.